#AUROPHARMA | 📌 Aurobindo Pharma announced its Q2FY25 results: Revenue from operations rose 8.0% YoY to INR 7,796 Cr. US formulations revenue grew 4.3% YoY to INR 3,530 Cr. Net profit is INR 817 Cr. Earnings call on November 11, 2024.

Details:⚡ AI powered update byCheck-outto receive WhatsApp updates faster than twitter/X.